Mizuho Markets Americas LLC Has $241 Million Stake in GE HealthCare Technologies Inc. $GEHC

Mizuho Markets Americas LLC trimmed its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 38.5% during the third quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 3,209,000 shares of the company’s stock after selling 2,009,000 shares during the quarter. GE HealthCare Technologies makes up 4.5% of Mizuho Markets Americas LLC’s holdings, making the stock its 6th largest position. Mizuho Markets Americas LLC owned about 0.70% of GE HealthCare Technologies worth $240,996,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Godsey & Gibb Inc. acquired a new position in shares of GE HealthCare Technologies during the 3rd quarter worth approximately $26,000. E Fund Management Hong Kong Co. Ltd. increased its holdings in shares of GE HealthCare Technologies by 130.7% in the third quarter. E Fund Management Hong Kong Co. Ltd. now owns 346 shares of the company’s stock valued at $26,000 after purchasing an additional 196 shares during the last quarter. Allianz SE raised its holdings in GE HealthCare Technologies by 165.2% in the 2nd quarter. Allianz SE now owns 350 shares of the company’s stock valued at $26,000 after acquiring an additional 218 shares during the period. Gladwyn Financial Advisors Inc. acquired a new stake in GE HealthCare Technologies during the second quarter worth approximately $34,000. Finally, Piscataqua Savings Bank boosted its holdings in shares of GE HealthCare Technologies by 173.4% during the third quarter. Piscataqua Savings Bank now owns 473 shares of the company’s stock worth $36,000 after acquiring an additional 300 shares during the period. Institutional investors own 82.06% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts recently weighed in on the company. Bank of America lifted their price target on GE HealthCare Technologies from $82.00 to $92.00 and gave the stock a “neutral” rating in a report on Monday, January 5th. The Goldman Sachs Group reissued a “buy” rating and issued a $98.00 target price on shares of GE HealthCare Technologies in a research report on Friday, January 9th. Zacks Research lowered shares of GE HealthCare Technologies from a “strong-buy” rating to a “hold” rating in a research report on Monday, September 29th. Evercore ISI reissued an “outperform” rating and issued a $95.00 price objective on shares of GE HealthCare Technologies in a report on Monday, January 5th. Finally, Citigroup raised their target price on shares of GE HealthCare Technologies from $83.00 to $88.00 and gave the stock a “neutral” rating in a report on Thursday, December 11th. Seven analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $89.83.

GE HealthCare Technologies Price Performance

GEHC stock opened at $81.75 on Monday. The company’s 50-day moving average price is $81.29 and its two-hundred day moving average price is $77.05. The firm has a market cap of $37.24 billion, a P/E ratio of 16.89, a P/E/G ratio of 3.18 and a beta of 1.08. The company has a quick ratio of 0.95, a current ratio of 1.18 and a debt-to-equity ratio of 0.83. GE HealthCare Technologies Inc. has a 12 month low of $57.65 and a 12 month high of $94.80.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings results on Wednesday, October 29th. The company reported $1.07 earnings per share for the quarter, topping analysts’ consensus estimates of $1.05 by $0.02. GE HealthCare Technologies had a net margin of 10.94% and a return on equity of 22.52%. The company had revenue of $5.14 billion during the quarter, compared to the consensus estimate of $5.07 billion. During the same quarter in the prior year, the firm posted $1.14 EPS. The firm’s quarterly revenue was up 5.8% on a year-over-year basis. GE HealthCare Technologies has set its FY 2025 guidance at 4.510-4.630 EPS. On average, analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, February 13th. Investors of record on Friday, January 9th will be given a dividend of $0.035 per share. This represents a $0.14 annualized dividend and a dividend yield of 0.2%. The ex-dividend date is Friday, January 9th. GE HealthCare Technologies’s dividend payout ratio is currently 2.89%.

About GE HealthCare Technologies

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.